- Defense
- Robotics
- Autonomy(coming soon)
- Mobility(coming soon)
- Space Tech(coming soon)
- Brain-Computer Interfaces
- Spatial Computing
- Voice & Conversational Interfaces
- Avatars & Digital Humans(coming soon)
- Smart Homes(coming soon)
- Wearables(coming soon)
- Health Tech
- Biotech / Synthetic Biology(coming soon)
- Healthcare Systems(coming soon)
- Longevity & Human Enhancement(coming soon)
- Data Infrastructure
- Payments & Financial Infrastructure
- Blockchain / Crypto(coming soon)
- Cloud & Edge Computing(coming soon)
- Cybersecurity(coming soon)
- Digital Identity(coming soon)
- Creative AI & Media
- Energy
- Manufacturing
- Agriculture Tech(coming soon)
- Climate Tech(coming soon)
- Commerce(coming soon)
- Education Tech(coming soon)
- Fashion & Textiles(coming soon)
- Food Tech(coming soon)
- Materials Science(coming soon)

- Defense
- Robotics
- Autonomy(coming soon)
- Mobility(coming soon)
- Space Tech(coming soon)
- Brain-Computer Interfaces
- Spatial Computing
- Voice & Conversational Interfaces
- Avatars & Digital Humans(coming soon)
- Smart Homes(coming soon)
- Wearables(coming soon)
- Health Tech
- Biotech / Synthetic Biology(coming soon)
- Healthcare Systems(coming soon)
- Longevity & Human Enhancement(coming soon)
- Data Infrastructure
- Payments & Financial Infrastructure
- Blockchain / Crypto(coming soon)
- Cloud & Edge Computing(coming soon)
- Cybersecurity(coming soon)
- Digital Identity(coming soon)
- Creative AI & Media
- Energy
- Manufacturing
- Agriculture Tech(coming soon)
- Climate Tech(coming soon)
- Commerce(coming soon)
- Education Tech(coming soon)
- Fashion & Textiles(coming soon)
- Food Tech(coming soon)
- Materials Science(coming soon)

Abbott vs NeuroPace — side-by-side comparison · fobi

- Defense
- Robotics
- Autonomy(coming soon)
- Mobility(coming soon)
- Space Tech(coming soon)
- Brain-Computer Interfaces
- Spatial Computing
- Voice & Conversational Interfaces
- Avatars & Digital Humans(coming soon)
- Smart Homes(coming soon)
- Wearables(coming soon)
- Health Tech
- Biotech / Synthetic Biology(coming soon)
- Healthcare Systems(coming soon)
- Longevity & Human Enhancement(coming soon)
- Data Infrastructure
- Payments & Financial Infrastructure
- Blockchain / Crypto(coming soon)
- Cloud & Edge Computing(coming soon)
- Cybersecurity(coming soon)
- Digital Identity(coming soon)
- Creative AI & Media
- Energy
- Manufacturing
- Agriculture Tech(coming soon)
- Climate Tech(coming soon)
- Commerce(coming soon)
- Education Tech(coming soon)
- Fashion & Textiles(coming soon)
- Food Tech(coming soon)
- Materials Science(coming soon)

Compare

Abbott vs NeuroPace

Side-by-side on funding, valuation, status, and the rest of the FOBI roster.

Brain-Computer Interfaces

Abbott

Offers spinal cord stimulation, dorsal root ganglion stimulation, and deep brain stimulation systems for chronic pain and movement disorders.

Brain-Computer Interfaces

NeuroPace

Develops the RNS System, a responsive neurostimulation device that detects and treats epileptic seizures in real time.

For subscribers

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →

Field	Abbott	NeuroPace
Status	Public · ABT	Public · NPCE
Sector	Brain-Computer Interfaces	Brain-Computer Interfaces
Subsector	Neuromodulation & Stimulation	Neuromodulation & Stimulation
Founded	—	1997
HQ	Chicago, United States	Mountain View, United States
Headcount	10k+	201-500
Total raised	—	$105.2M